{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:53:21Z","timestamp":1786708401531,"version":"build-2736575974"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>In recent years, research in the areas of Aspergillus and aspergillosis has continued to advance rapidly, including advancements in genomics, immunological studies, clinical areas, and diagnostic areas. Recently, new risk groups for the development of aspergillosis have emerged\u2014patients with influenza- or COVID-19-ssociated pulmonary aspergillosis. The rise and spread of antifungal resistances have also become a clinical concern in some geographic areas and have drawn the attention of clinicians due to difficulties in treating these infections. In this paper, a snapshot of these issues is presented, emphasizing these novel clinical and laboratorial challenges in the aspergillosis field and focusing on their actual relevance.<\/jats:p>","DOI":"10.3390\/microorganisms10020259","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:40:18Z","timestamp":1643143218000},"page":"259","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel Clinical and Laboratorial Challenges in Aspergillosis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-7775","authenticated-orcid":false,"given":"Raquel","family":"Sabino","sequence":"first","affiliation":[{"name":"Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, 1649-016 Lisbon, Portugal"},{"name":"Instituto de Sa\u00fade Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ver\u00edssimo","sequence":"additional","affiliation":[{"name":"Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, 1649-016 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_2","unstructured":"(2021, December 09). New Study Finds Invasive Aspergillosis (IA) Affects up to 2 million People with Chronic Obstructive Pulmonary Disease (COPD) Globally. Available online: http:\/\/www.life-worldwide.org\/fungal-diseases\/invasive-aspergillosis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","article-title":"Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: A 10-year, single-center experience","volume":"15","author":"Neofytos","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Snelders, E., van der Lee, H.A., Kuijpers, J., Rijs, A.J., Varga, J., Samson, R.A., Mellado, E., Donders, A.R., Melchers, W.J., and Verweij, P.E. (2008). Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism. PLoS Med., 5.","DOI":"10.4016\/8254.01"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob. Agents Chemother"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole Resistance in Aspergillus fumigatus: Can We Retain the Clin-ical Use of Mold-Active Antifungal Azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","first-page":"371","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"5","author":"Meis","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00791-17","DOI":"10.1128\/mBio.00791-17","article-title":"A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence","volume":"8","author":"Zhang","year":"2017","journal-title":"mBio"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3201\/eid2503.180297","article-title":"In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) inAspergillus fumigatus cyp51A, Denmark","volume":"25","author":"Hare","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: A growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Faria-Ramos, I., Farinha, S., Neves-Maia, J., Tavares, P.R., Miranda, I.M., Estevinho, L.M., Pina-Vaz, C., and Rodrigues, A.G. (2014). Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole. BMC Microbiol., 14.","DOI":"10.1186\/1471-2180-14-155"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3114\/sim.2007.59.05","article-title":"Aspergillus species identification in the clinical setting","volume":"59","author":"Balajee","year":"2007","journal-title":"Stud. Mycol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.simyco.2021.100115","article-title":"Aspergillus fumigatus and aspergillosis: From basics to clinics","volume":"100","author":"Arastehfar","year":"2021","journal-title":"Stud. Mycol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/JCM.01704-14","article-title":"Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species","volume":"52","author":"Sugui","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillusspecies intrinsically resistant to antifungal agents","volume":"49","author":"Warris","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/myc.13348","article-title":"Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study","volume":"64","author":"Imbert","year":"2021","journal-title":"Mycoses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11046-014-9774-0","article-title":"Multi-Resistant Aspergillosis due to Cryptic Species","volume":"178","author":"Howard","year":"2014","journal-title":"Mycopathologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"ii27","DOI":"10.1093\/jac\/dkz041","article-title":"Diagnosis and treatment of invasive fungal infections: Looking ahead","volume":"74","author":"Sanguinetti","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wall, G., and Lopez-Ribot, J.L. (2020). Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080445"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hou\u0161\u0165, J., Sp\u00ed\u017eek, J., and Havl\u00ed\u010dek, V. (2020). Antifungal Drugs. Metabolites, 10.","DOI":"10.3390\/metabo10030106"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mib.2021.04.006","article-title":"Invasive pulmonary aspergillosis associated with viral pneumonitis","volume":"62","author":"Dewi","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13054-020-2808-8","article-title":"International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: Responses suggest low awareness and potential underdiagnosis outside Europe","volume":"24","author":"Thevissen","year":"2020","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1265","DOI":"10.1097\/CCM.0000000000005238","article-title":"Influenza-Associated Pulmonary Aspergillosis: Seek, and You Shall Find!","volume":"49","author":"Feys","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Dutch-Belgian Mycosis study group. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1080\/21505594.2021.1974327","article-title":"Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model","volume":"12","author":"Seldeslachts","year":"2021","journal-title":"Virulence"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): A systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Reizine, F., Pinceaux, K., Lederlin, M., Autier, B., Guegan, H., Gacouin, A., Luque-Paz, D., Boglione-Kerrien, C., Bacle, A., and Le Dar\u00e9, B. (2021). Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?. J. Fungi, 7.","DOI":"10.21203\/rs.3.rs-331976\/v1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100289","DOI":"10.1016\/j.xcrm.2021.100289","article-title":"Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis","volume":"2","author":"Dewi","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.202012-4413ED","article-title":"Invasive Pulmonary Aspergillosis Goes Viral Again?","volume":"203","author":"Wauters","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","article-title":"Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis","volume":"56","author":"Youngs","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensiv. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12281-020-00409-z","article-title":"The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: An Update","volume":"14","author":"Jenks","year":"2020","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis","volume":"15","author":"Thornton","year":"2008","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/2\/259\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:06:31Z","timestamp":1760133991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/2\/259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["microorganisms10020259"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10020259","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}